96 related articles for article (PubMed ID: 30184235)
1. Effect of MAPK Inhibition on the Differentiation of a Rhabdomyosarcoma Cell Line Combined With CRISPR/Cas9 Technology: An In Vitro Model of Human Muscle Diseases.
De Luna N; Suarez-Calvet X; Garicano M; Fernandez-Simon E; Rojas-García R; Diaz-Manera J; Querol L; Illa I; Gallardo E
J Neuropathol Exp Neurol; 2018 Oct; 77(10):964-972. PubMed ID: 30184235
[TBL] [Abstract][Full Text] [Related]
2. MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals.
Marampon F; Gravina GL; Di Rocco A; Bonfili P; Di Staso M; Fardella C; Polidoro L; Ciccarelli C; Festuccia C; Popov VM; Pestell RG; Tombolini V; Zani BM
Mol Cancer Ther; 2011 Jan; 10(1):159-68. PubMed ID: 21220498
[TBL] [Abstract][Full Text] [Related]
3. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
4. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes.
Andrieux L; Langouët S; Fautrel A; Ezan F; Krauser JA; Savouret JF; Guengerich FP; Baffet G; Guillouzo A
Mol Pharmacol; 2004 Apr; 65(4):934-43. PubMed ID: 15044623
[TBL] [Abstract][Full Text] [Related]
5. U0126 prevents ERK pathway phosphorylation and interleukin-1beta mRNA production after cerebral ischemia.
Wang ZQ; Chen XC; Yang GY; Zhou LF
Chin Med Sci J; 2004 Dec; 19(4):270-5. PubMed ID: 15669185
[TBL] [Abstract][Full Text] [Related]
6. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
7. Protection against glutamate toxicity through inhibition of the p44/42 mitogen-activated protein kinase pathway in neuronally differentiated P19 cells.
Grant ER; Errico MA; Emanuel SL; Benjamin D; McMillian MK; Wadsworth SA; Zivin RA; Zhong Z
Biochem Pharmacol; 2001 Aug; 62(3):283-96. PubMed ID: 11434901
[TBL] [Abstract][Full Text] [Related]
8. U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells.
Ge X; Fu YM; Meadows GG
Cancer Lett; 2002 May; 179(2):133-40. PubMed ID: 11888667
[TBL] [Abstract][Full Text] [Related]
9. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
Yip-Schneider MT; Schmidt CM
Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
[TBL] [Abstract][Full Text] [Related]
11. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
12. The mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor PD184352 (CI-1040) selectively induces apoptosis in malignant schwannoma cell lines.
Mattingly RR; Kraniak JM; Dilworth JT; Mathieu P; Bealmear B; Nowak JE; Benjamins JA; Tainsky MA; Reiners JJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):456-65. PubMed ID: 16239399
[TBL] [Abstract][Full Text] [Related]
13. Transfected beta3- but not beta2-adrenergic receptors regulate cystic fibrosis transmembrane conductance regulator activity via a new pathway involving the mitogen-activated protein kinases extracellular signal-regulated kinases.
Robay A; Toumaniantz G; Leblais V; Gauthier C
Mol Pharmacol; 2005 Mar; 67(3):648-54. PubMed ID: 15563584
[TBL] [Abstract][Full Text] [Related]
14. [Wortmannin and U0126 inhibit the promoting effect of insulin on differentiation of skeletal myoblasts in rats].
Zhou X; Zhao Y; Xu L; Li X; Chen P; Zou H; Yu H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):717-20. PubMed ID: 25001936
[TBL] [Abstract][Full Text] [Related]
15. DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation.
Megiorni F; Camero S; Ceccarelli S; McDowell HP; Mannarino O; Marampon F; Pizer B; Shukla R; Pizzuti A; Marchese C; Clerico A; Dominici C
Oncotarget; 2016 Nov; 7(48):79342-79356. PubMed ID: 27764816
[TBL] [Abstract][Full Text] [Related]
16. MEK modulates force-fluctuation-induced relengthening of canine tracheal smooth muscle.
Dowell ML; Lavoie TL; Lakser OJ; Dulin NO; Fredberg JJ; Gerthoffer WT; Seow CY; Mitchell RW; Solway J
Eur Respir J; 2010 Sep; 36(3):630-7. PubMed ID: 20110395
[TBL] [Abstract][Full Text] [Related]
17. U0126 reverses Ki-ras-mediated transformation by blocking both mitogen-activated protein kinase and p70 S6 kinase pathways.
Fukazawa H; Uehara Y
Cancer Res; 2000 Apr; 60(8):2104-7. PubMed ID: 10786668
[TBL] [Abstract][Full Text] [Related]
18. Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population.
Ciccarelli C; Vulcano F; Milazzo L; Gravina GL; Marampon F; Macioce G; Giampaolo A; Tombolini V; Di Paolo V; Hassan HJ; Zani BM
Mol Cancer; 2016 Feb; 15():16. PubMed ID: 26897742
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
20. Blockades of mitogen-activated protein kinase and calcineurin both change fibre-type markers in skeletal muscle culture.
Higginson J; Wackerhage H; Woods N; Schjerling P; Ratkevicius A; Grunnet N; Quistorff B
Pflugers Arch; 2002 Dec; 445(3):437-43. PubMed ID: 12466948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
